Cochrane Abstracts
Rituximab as maintenance therapy for patients with follicular lymphoma
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Rituximab as Maintenance Therapy for Patients With Follicular Lymphoma." Cochrane Abstracts, John Wiley & Sons, Inc, 2026. Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/433738/all/Rituximab_as_maintenance_therapy_for_patients_with_follicular_lymphoma.
Rituximab as maintenance therapy for patients with follicular lymphoma. Cochrane Abstracts. John Wiley & Sons, Inc; 2026. https://evidence.unboundmedicine.com/evidence/view/Cochrane/433738/all/Rituximab_as_maintenance_therapy_for_patients_with_follicular_lymphoma. Accessed January 20, 2026.
Rituximab as maintenance therapy for patients with follicular lymphoma. (2026). In Cochrane Abstracts. John Wiley & Sons, Inc. https://evidence.unboundmedicine.com/evidence/view/Cochrane/433738/all/Rituximab_as_maintenance_therapy_for_patients_with_follicular_lymphoma
Rituximab as Maintenance Therapy for Patients With Follicular Lymphoma [Internet]. In: Cochrane Abstracts. John Wiley & Sons, Inc; 2026. [cited 2026 January 20]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/433738/all/Rituximab_as_maintenance_therapy_for_patients_with_follicular_lymphoma.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Rituximab as maintenance therapy for patients with follicular lymphoma
ID - 433738
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/433738/all/Rituximab_as_maintenance_therapy_for_patients_with_follicular_lymphoma
PB - John Wiley & Sons, Inc
DB - Evidence Central
DP - Unbound Medicine
ER -
